Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Hematology-Oncology Clinical Questions

Hematology-Oncology Clinical Questions

9781260026627
Print on demand. This item has an extended shipping time. The typical delivery time is 4-8 weeks.
408,18 zł
387,77 zł Zniżka 20,41 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 387,77 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
A unique point-of-care guide to clinical hematology-oncology

Hematology-Oncology Clinical Questions answers the questions most frequently asked by medical students or residents on rotations. The answers provided are concise, specific, evidence-based, and supported by recent references and clinical practice guidelines. Readers will find Hematology-Oncology Clinical Questions to be single-best resource for quickly translating the most current knowledge into practical, diagnostic real-time solutions. 

• Coverage includes both solid tumor and hematology malignancies, cancer screening and genetic and familial cancer syndrome, supportive care and end of life, chemotherapy agents (including immunotherapy)
• The content arrangement is designed to simulate the consultation process:: data collection, synthesis of data, solution

Szczegóły produktu
McGraw Hill / Medical
60941
9781260026627
9781260026627

Opis

Rok wydania
2019
Numer wydania
1
Oprawa
miękka foliowana
Wymiary (mm)
114 x 178
Waga (g)
413

  • Table of Contents

     

    1. CHEMOTHERAPY AGENTS –WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS

    a. Cytotoxic

    b. Targeted Agents

    c. Hormonal Agents

    d. Immunotherapy

    2. RADIATION THERAPY

    3. MOST COMMON HEME QUESTIONS

    a. Anemia

    b. Thrombocytopenia

    c. Thrombosis

    d. Transfusion reactions

    4. SCREENING

    a. Breast cancer

    b. Cervical

    c. Colon Cancer

    d. Prostate

    e. Lung Cancer

    5. BREAST CANCER

    a. Non-invasive

    b. Invasive

    c. Inflammatory breast cancer

    d. Phyllodes

    e. Pagets

    6. HEAD AND NECK

    7. THYROID CARCINOMAS

    8. GI CANCER

    a. Esophagus

    b. Gastric/GEJ

    c. Colon

    d. Rectal

    e. Anus

    f. Pancreas

    g. Cholangiocarcinoma

    h. Hepatocellular Carcinoma

    i. Neuroendocrine tumors

    9. GU CANCER

    a. Bladder

    b. Kidney

    c. Prostate

    d. Testicular

    10. GYNECOLOGICAL MALIGNANCIES

    a. Cervical

    b. Endometrial

    c. Ovarian

    d. Uterine

    11. MELANOMAS

    12. THORACIC

    a. Small cell lung cancer

    b. Non-small cell lung cancer

    13. SARCOMAS

    14. OCCULT PRIMARY

    15. BASICS OF PATHOLOGY AND HEMATOLOGY

    a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.

    b. Solid tumor pathology basics

    16. BASICS OF BONE MARROW TRANSPLANTATION

    a. Types (Allo, Auto)

    b. Indications

    17. LYMPHOMAS

    a. Hodgkins Lymphoma

    i. Classical HL

    ii. Nodular lymphocyte-predominant HL

    b. Non-Hodgkins Lymphoma

    i. B-cell NHL

    a) Diffuse large B-cell Lymphoma (DLBCL)

    b) Follicular Lymphoma

    c) Mantle Cell Lymphoma (MCL)

    d) Small Lymphocytic Lymphoma (SLL)

    e) Primary CNS Lymphoma

    f) Primary Mediastinal Lymphoma (PML)

    g) Burkitt Lymphoma (BL)

    h) Primary Effusion Lymphoma

    i) Double-hit Lymphoma

    j) Primary Effusion Lymphoma (PEL)

    ii. T-Cell NHL

    a) Peripheral T-cell Lymphoma (PTCL)

    b) Primary Cutaneous T-cell Lymphoma

    c) Anaplastic Large Cell Lymphoma (ALCL)

    d) Post-Transplant Lymphoproliferative

    18. LEUKEMIAS

    a) Acute Leukemias

    i. Acute Myeloid Leukemia (AML)

    ii. APL

    i. Acute Lymphoblastic Leukemia (ALL)

    b) Chronic Leukemias:

    i. Chronic Myeloid Leukemia (CML)

    ii. Chronic Lymphocytic Leukemia (CLL)

    iii. Hairy Cell Leukemia

    19. PLASMA CELL DISORDERS:

    a. Monoclonal Gammopathy of Undetermined Significance (MGUS)

    b. Multiple Myeloma (MM)

    c. Lymphoplasmacyctic Lymphoma (including Waldenstroms Macroglobulinemia)

    d. Solitary Plasmacytoma

    e. AL Amyloidosis

    f. POEMS Syndrome

    20. MYELOPROLIFERATIVE NEOPLASMS

    a. Polycythemia Vera (PV)

    b. Essential Thrombocythemia (ET)

    c. Primary Myelofibrosis (PMF)

    d. Systemic Mastocytosis (SM)

    21. MYELODYSPLASTIC SYNDROMES

    22. GUIDELINES FOR SUPPORTIVE CARE

    a. Management of Side Effects of Chemotherapy

    i. Myelosuppression

    ii. Nausea

    iii. Vomiting

    iv. Diarrhea

    v. Mucositis

    vi. Anorexia, weight loss

    b. Management of Cancer-related pain

    c. Management of Cachexia

    23. ONCOLOGIC EMERGENCIES

    a. Neutropenic Fever

    b. Spinal Cord Compression

    c. Tumor Lysis Syndrome

    d. Superior vena cava syndrome

    e. Hypercalcemia of malignancy

    f. Hyperleukocytosis and leukostasis

    24. GENETIC AND FAMILIAL ASSESSMENT FOR FAMILIAL CANCER SYNDROMES

    25. END OF LIFE

Komentarze (0)